NERV: Minerva Neurosciences Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Minerva Neurosciences Inc (NERV).

OverviewDividends

$15.54M Market Cap.

As of 05/14/2025 5:00 PM ET (MRY) • Disclaimer

NERV Market Cap. (MRY)


NERV Shares Outstanding (MRY)


NERV Assets (MRY)


Total Assets

$37.14M

Total Liabilities

$62.84M

Total Investments

$0

NERV Income (MRY)


Revenue

$0

Net Income

$1.44M

Operating Expense

$21.85M

NERV Cash Flow (MRY)


CF Operations

-$19.55M

CF Investing

$0

CF Financing

$0

NERV Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$37,143,744 (-34.72%)

$56,899,750 (3.29%)

$55,087,233 (-28.57%)

$77,121,918 (33.83%)

Assets Current

$22,268,903 (-46.98%)

$42,002,440 (4.59%)

$40,158,941 (-35.44%)

$62,201,439 (126.68%)

Assets Non-Current

$14,874,841 (-0.15%)

$14,897,310 (-0.21%)

$14,928,292 (0.05%)

$14,920,479 (-50.57%)

Goodwill & Intangible Assets

$14,869,399 (-0.11%)

$14,886,426 (-0.17%)

$14,911,966 (-0.06%)

$14,920,479 (0.34%)

Shareholders Equity

-$25,693,100 (9.71%)

-$28,457,490 (-42.12%)

-$20,024,219 (-351.07%)

$7,975,643 (-84.86%)

Property Plant & Equipment Net

$5,442 (-50.00%)

$10,884 (-33.33%)

$16,326 (0%)

$0 (0%)

Cash & Equivalents

$21,462,008 (-47.67%)

$41,012,575 (13.31%)

$36,193,606 (-40.52%)

$60,855,080 (139.05%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$1,607,844 (-10.94%)

$1,805,320 (86.18%)

$969,667 (-47.68%)

$1,853,215 (86.14%)

Accumulated Retained Earnings (Deficit)

-$395,376,563 (0.36%)

-$396,815,428 (-8.18%)

-$366,810,075 (-9.59%)

-$334,701,399 (-17.52%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$60,000,000 (-26.84%)

$82,016,823 (11.23%)

$73,733,876 (11.17%)

$66,327,321 (59531.32%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$60,000,000 (-26.84%)

$82,016,823 (11.23%)

$73,733,876 (11.17%)

$66,327,321 (0%)

Total Liabilities

$62,836,844 (-26.38%)

$85,357,240 (13.64%)

$75,111,452 (8.63%)

$69,146,275 (1293.06%)

Liabilities Current

$2,836,844 (-15.08%)

$3,340,417 (142.49%)

$1,377,576 (-51.13%)

$2,818,954 (-10.80%)

Liabilities Non-Current

$60,000,000 (-26.84%)

$82,016,823 (11.23%)

$73,733,876 (11.17%)

$66,327,321 (3577.99%)

NERV Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$9,949,791 (-4.46%)

$10,414,323 (-1.59%)

$10,582,239 (-20.59%)

$13,326,710 (-22.92%)

Research & Development Expense

$11,898,595 (-6.35%)

$12,705,253 (-13.27%)

$14,649,087 (-54.28%)

$32,038,947 (45.37%)

Operating Expenses

$21,848,386 (-5.50%)

$23,119,576 (-8.37%)

$25,231,326 (-44.38%)

$45,365,657 (15.35%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

-$1,803,356 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$1,438,865 (104.80%)

-$30,005,353 (6.55%)

-$32,108,676 (35.66%)

-$49,905,952 (-2671.45%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$1,438,865 (104.80%)

-$30,005,353 (6.55%)

-$32,108,676 (35.66%)

-$49,905,952 (-2671.45%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$1,438,865 (104.80%)

-$30,005,353 (6.55%)

-$32,108,676 (35.66%)

-$49,905,952 (-2671.45%)

Weighted Average Shares

$7,568,981 (16.33%)

$6,506,372 (21.84%)

$5,340,194 (-0.00%)

$5,340,196 (4.65%)

Weighted Average Shares Diluted

$7,573,763 (16.41%)

$6,506,372 (21.84%)

$5,340,194 (-0.00%)

$5,340,196 (4.41%)

Earning Before Interest & Taxes (EBIT)

$1,438,865 (104.80%)

-$30,005,353 (6.55%)

-$32,108,676 (37.91%)

-$51,709,308 (-2764.37%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$21,848,386 (5.50%)

-$23,119,576 (8.37%)

-$25,231,326 (44.38%)

-$45,365,657 (-2556.52%)

NERV Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$0 (0%)

-$16,326 (0%)

$0 (0%)

Net Cash Flow from Financing

$0 (0%)

$19,603,701 (392074120.00%)

-$5 (-100.00%)

$60,000,000 (353.24%)

Net Cash Flow from Operations

-$19,550,567 (-32.23%)

-$14,784,732 (40.01%)

-$24,645,143 (-0.18%)

-$24,601,872 (27.26%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$19,550,567 (-505.70%)

$4,818,969 (119.54%)

-$24,661,474 (-169.67%)

$35,398,128 (797.44%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

-$16,326 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$60,000,000 (0%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$19,999,994 (0%)

$0 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,325,525 (-32.66%)

$1,968,381 (-52.09%)

$4,108,819 (-21.27%)

$5,218,994 (-46.22%)

Depreciation Amortization & Accretion

$22,469 (-27.48%)

$30,982 (263.94%)

$8,513 (-91.64%)

$101,786 (-42.23%)

NERV Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-4.50% (-103.28%)

137.00% (-53.72%)

296.00% (274.32%)

-169.80% (-4142.86%)

Return on Average Assets (ROAA)

3.30% (106.56%)

-50.30% (1.95%)

-51.30% (-0.79%)

-50.90% (-1796.67%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

2.10% (105.38%)

-39.00% (14.10%)

-45.40% (35.79%)

-70.70% (-605.00%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

11.69 (976.54%)

-1.33 (-403.40%)

-0.27 (61.31%)

-0.69 (-101.46%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

-0.6 (59.96%)

-1.51 (-256.37%)

-0.42 (-109.88%)

4.29 (126.32%)

Debt to Equity Ratio (D/E)

-2.45 (18.44%)

-3 (20.05%)

-3.75 (-143.26%)

8.67 (9123.40%)

Earnings Per Share (EPS)

0.19 (104.12%)

-4.61 (23.29%)

-6.01 (35.72%)

-9.35 (-2437.50%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-2.58 (-13.69%)

-2.27 (50.80%)

-4.62 (-0.24%)

-4.61 (30.49%)

Book Value Per Share (BVPS)

-3.4 (22.38%)

-4.37 (-16.64%)

-3.75 (-351.00%)

1.49 (-85.52%)

Tangible Assets Book Value Per Share (TABVPS)

2.94 (-54.42%)

6.46 (-14.17%)

7.52 (-35.41%)

11.65 (39.01%)

Enterprise Value Over EBIT (EV/EBIT)

34 (1233.33%)

-3 (-200.00%)

-1 (0.00%)

-1 (-102.86%)

Enterprise Value Over EBITDA (EV/EBITDA)

33.47 (1422.85%)

-2.53 (-103.21%)

-1.25 (-93.93%)

-0.64 (-102.02%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

7.85 (-37.57%)

12.57 (-56.87%)

29.15 (32.12%)

22.07 (154.12%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$19,550,567 (-32.23%)

-$14,784,732 (40.05%)

-$24,661,469 (-0.24%)

-$24,601,872 (27.26%)

Enterprise Value (EV)

$48,907,759 (-35.51%)

$75,832,158 (89.68%)

$39,978,995 (20.68%)

$33,126,840 (-50.85%)

Earnings Before Tax (EBT)

$1,438,865 (104.80%)

-$30,005,353 (6.55%)

-$32,108,676 (37.91%)

-$51,709,308 (-2764.37%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$1,461,334 (104.88%)

-$29,974,371 (6.62%)

-$32,100,163 (37.80%)

-$51,607,522 (-2537.83%)

Invested Capital

$57,975,493 (-27.24%)

$79,677,155 (4.37%)

$76,337,961 (17.71%)

$64,854,726 (355.09%)

Working Capital

$19,432,059 (-49.74%)

$38,662,023 (-0.31%)

$38,781,365 (-34.69%)

$59,382,485 (144.57%)

Tangible Asset Value

$22,274,345 (-46.98%)

$42,013,324 (4.58%)

$40,175,267 (-35.41%)

$62,201,439 (45.48%)

Market Capitalization

$15,536,551 (-63.88%)

$43,009,447 (406.54%)

$8,490,907 (-75.19%)

$34,219,974 (-65.73%)

Average Equity

-$32,110,716 (-46.57%)

-$21,908,164 (-101.97%)

-$10,847,110 (-136.90%)

$29,399,088 (-36.86%)

Average Assets

$44,189,334 (-25.97%)

$59,690,860 (-4.66%)

$62,605,828 (-36.09%)

$97,959,459 (51.99%)

Invested Capital Average

$69,941,690 (-8.98%)

$76,846,249 (8.74%)

$70,671,841 (-3.41%)

$73,165,764 (428.30%)

Shares

6,993,406 (0.00%)

6,993,406 (30.96%)

5,340,193 (-0.00%)

5,340,196 (0.11%)